These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. International intellectual property, access to health care, and human rights: South Africa v. United States. Nagan WP. Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137 [No Abstract] [Full Text] [Related]
6. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S. Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]
9. Experts clash over likely impact of cheap AIDS drugs in Africa. Wadman M. Nature; 2001 Apr 05; 410(6829):615-6. PubMed ID: 11287906 [No Abstract] [Full Text] [Related]
10. Access to HIV drugs: are we changing the two world paradigm? Lazzarini Z. Conn J Int Law; 2002 Apr 05; 17(2):281-96. PubMed ID: 12688297 [No Abstract] [Full Text] [Related]
12. Essential AIDS medications in India. Thomas J. Issues Med Ethics; 2000 Apr 05; 8(2):62. PubMed ID: 16323350 [No Abstract] [Full Text] [Related]
13. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Cohen J. Science; 2006 Jul 28; 313(5786):484-7. PubMed ID: 16873654 [No Abstract] [Full Text] [Related]
16. Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives. Schüklenk U, Ashcroft RE. J Med Philos; 2002 Apr 28; 27(2):179-95. PubMed ID: 11961696 [Abstract] [Full Text] [Related]
17. Improving access to essential drugs for people living with HIV/AIDS. Balasubramaniam K. Issues Med Ethics; 2000 Apr 28; 8(1):26-7. PubMed ID: 16323335 [No Abstract] [Full Text] [Related]
18. The role of civil society in protecting public health over commercial interests: lessons from Thailand. Ford N, Wilson D, Bunjumnong O, von Schoen Angerer T. Lancet; 2004 Feb 14; 363(9408):560-3. PubMed ID: 14975620 [No Abstract] [Full Text] [Related]